These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 8438342)
21. Reversibility from delayed hyperacute rejection in ABO-incompatible renal transplantation: histopathological findings of renal allograft biopsy. Sugiyama K; Arai K; Aikawa A; Miyagi M; Ohara T; Hasegawa A; Muramatsu M; Hirayama N; Tajima E; Kawamura T; Ogihara H; Hadano T; Nakano H Transplant Proc; 2005 Mar; 37(2):701-4. PubMed ID: 15848507 [TBL] [Abstract][Full Text] [Related]
22. Improved graft survival in ABO-incompatible living donor kidney transplantation. Kaihara S; Okamoto M; Akioka K; Ogino S; Higuchi A; Kadotani Y; Nobori S; Yoshimura N Transplant Proc; 2005 May; 37(4):1804-5. PubMed ID: 15919472 [TBL] [Abstract][Full Text] [Related]
23. Delayed xenograft rejection in C3-depleted discordant (pig-to-baboon) cardiac xenografts treated with cobra venom factor. Kobayashi T; Taniguchi S; Ye Y; Niekrasz M; Kosanke S; Neethling FA; Wright LJ; Rose AG; White DJ; Cooper DK Transplant Proc; 1996 Apr; 28(2):560. PubMed ID: 8623270 [No Abstract] [Full Text] [Related]
24. Detection of allogeneic blood group A and B enzyme activities in patients with ABO incompatible kidney transplantation. Tasaki M; Nakajima T; Imai N; Nakagawa Y; Saito K; Takahashi K; Yazawa S Glycobiology; 2010 Oct; 20(10):1251-8. PubMed ID: 20542872 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of two different preconditioning regimens for ABO-incompatible living kidney donor transplantation. A comparison of splenectomy vs. rituximab-treated non-splenectomy preconditioning regimens. Tanabe K; Ishida H; Shimizu T; Omoto K; Shirakawa H; Tokumoto T Contrib Nephrol; 2009; 162():61-74. PubMed ID: 19001814 [TBL] [Abstract][Full Text] [Related]
26. Newborn discordant cardiac xenotransplantation in primates: a model of natural antibody depletion. Michler RE; Xu H; O'Hair DP; Shah A; Kwiatkowski PA; Minanov O; Itescu S Transplant Proc; 1996 Apr; 28(2):651-2. PubMed ID: 8623325 [No Abstract] [Full Text] [Related]
27. [The role of humoral antibodies in the rejection of a kidney allograft (a review of the literature)]. Drannik GN; Driianskaia VE Vrach Delo; 1990 May; (5):45-9. PubMed ID: 2204199 [No Abstract] [Full Text] [Related]
28. Outcome of donor-specific skin graft is a reliable prognostic sign in ABO-incompatible live-donor renal transplants. Haberal M; Tokyay R; Bilgin N Transplant Proc; 1992 Dec; 24(6):2530-1. PubMed ID: 1465855 [No Abstract] [Full Text] [Related]
29. Is ABO compatibility essential in xenografting between closely related species? Cooper DK; Human PA; Rose AG Transplant Proc; 1987 Dec; 19(6):4437-40. PubMed ID: 3122389 [No Abstract] [Full Text] [Related]
30. From ABO-incompatible human kidney transplantation to xenotransplantation. Alexandre GP Xenotransplantation; 2004 May; 11(3):233-6. PubMed ID: 15099202 [TBL] [Abstract][Full Text] [Related]
31. A histopathologic grading system of hyperacute (humoral, antibody-mediated) cardiac xenograft and allograft rejection. Rose AG; Cooper DK J Heart Lung Transplant; 1996 Aug; 15(8):804-17. PubMed ID: 8878763 [TBL] [Abstract][Full Text] [Related]
33. Intravenous infusion of Galalpha1-3Gal oligosaccharides in baboons delays hyperacute rejection of porcine heart xenografts. Simon PM; Neethling FA; Taniguchi S; Goode PL; Zopf D; Hancock WW; Cooper DK Transplantation; 1998 Feb; 65(3):346-53. PubMed ID: 9484750 [TBL] [Abstract][Full Text] [Related]
34. Relation between ABO blood type antigen and antibody and acute vascular rejection in ABO incompatible kidney transplantation. Aikawa A; Hadano T; Ohara T; Hasegawa A; Yamashita M; Shindo M; Mizuiri T; Fushimi T; Sakai K; Hirayama N; Arai K; Tajima E Transplant Proc; 1998 Nov; 30(7):3507-9. PubMed ID: 9838538 [No Abstract] [Full Text] [Related]
35. Intravenous administration of alpha-galactosyl carbohydrates reduces in vivo baboon serum cytotoxicity to pig kidney cells and transplanted pig hearts. Ye Y; Neethling FA; Niekrasz M; Richards SV; Koren G; Merhav H; Kosanke S; Oriol R; Cooper DK Transplant Proc; 1994 Jun; 26(3):1399. PubMed ID: 8029958 [No Abstract] [Full Text] [Related]
36. Prolongation of survival of heterotopic heart xenografts by antibody and complement suppression in primates. Mieny CJ; Karusseit VO; Van den Bogaerde JB; Hasan RI; White DJ Transplant Proc; 1994 Jun; 26(3):1073. PubMed ID: 8029834 [No Abstract] [Full Text] [Related]
37. Rapid accomodation of an A1 renal allograft after preconditioning for ABO-incompatible transplantation. Allen G; Simpkins CE; Segev D; Warren D; King K; Taube J; Locke J; Baldwin W; Haas M; Chivukula R; Montgomery RA Contrib Nephrol; 2009; 162():35-46. PubMed ID: 19001812 [TBL] [Abstract][Full Text] [Related]
38. Xenoperfusion of pig kidney with human AB or O whole blood. Otte KE; Andersen N; Jørgensen KA; Kristensen T; Barfort P; Starklint H; Larsen S; Kemp E Transplant Proc; 1990 Jun; 22(3):1091-2. PubMed ID: 2349669 [No Abstract] [Full Text] [Related]
39. Clinicopathological analysis of rejection episodes in ABO-incompatible kidney transplantation. Tanabe K; Takahashi K; Sonda K; Onituka S; Yamaguchi Y; Agishi T; Koga S; Koga T; Nakazawa H; Goya N; Yagisawa T; Fuchinoue S; Kawai T; Toma H; Ota K Transplant Proc; 1996 Jun; 28(3):1447-8. PubMed ID: 8658734 [No Abstract] [Full Text] [Related]
40. Target antigen specificity of a monoclonal antibody (HAR-1) that causes the rejection of hamster heart xenografts in rats. Cramer DV; Wu GD; Oriol R; Makowka L Transplant Proc; 1995 Apr; 27(2):1575-6. PubMed ID: 7536970 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]